Skip to main content
ISTH 2023 Main banner
Back

    Ryan Zarychanski, MD, MSc, FRCPC

    Professor
    University of Manitoba
    Winnipeg, Manitoba, Canada

    Dr. Zarychanski is a Professor, Hematologist, Critical Care physician, and Clinician-Scientist at the University of Manitoba and CancerCare Manitoba. His research focuses on the hematologic aspects of critical illness where he leads several national and international randomized trials in the fields of sepsis, anticoagulation and transfusion medicine. He recently served as the Chair for recent adaptive platform trials evaluating anticoagulation strategies in COVID-19 and sepsis, and has contributed to the establishment of a novel trial methods of global collaboration in clinical trials, including the development of the multiplatform randomized trial (mpRCT).

    In collaboration with international partners and building on knowledge generated in COVID-19, Dr. Zarychanski, and co-PIs, in collaboration with CanVECTOR, INVENT, and the CCCTG, are conducting a large multi-national adaptive RCT evaluating therapeutic-dose heparin in non-Covid community acquired pneumonia (CAP). In Canada, Dr. Zarychanski co-chairs a multicenter RCT studying plasma exchange in septic shock and leads a large cluster-crossover trial to evaluate tranexamic to reduce transfusion in major non-cardiac surgery.

    Presentation(s):